Synthesis and characterization of novel astragalin galactosides using β-galactosidase from Bacillus circulans

Songhee Han, Thi Thanh Hanh Nguyen, Jaewon Hur, Nahyun M. Kim, Seong Bo Kim, Kyeong Hwan Hwang, Young Hwan Moon, Choongil Kang, Byoungsang Chung, Young Min Kim, Tae Sung Kim, Jun Seong Park, Doman Kim

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Astragalin (kaempferol-3-O-β-D-glucopyranoside, Ast) is a kind of flavonoid known to have anti-oxidant, anti-HIV, anti-allergic, and anti-inflammatory effects. It has low solubility in water. In this study, novel astragalin galactosides (Ast-Gals) were synthesized using β-galactosidase from Bacillus circulans and reaction conditions were optimized to increase the conversion yield of astragallin. Purified Ast-Gal1 (11.6% of Ast used, w/w) and Ast-Gal2 (6.7% of Ast used, w/w) were obtained by medium pressure chromatography (MPLC) with silica C18 column and open column packed with Sephadex LH-20. The structures of Ast-Gal1 and Ast-Gal2 were identified by nuclear magnetic resonance (NMR) to be kaempferol-3-O-β-D-glucopyranosyl-(1 → 6)-β-D-galactopyranoside and kaempferol-3-O-β-D-glucopyranosyl-(1 → 6)-β-D-galactopyranosyl-(1 → 4)-β-D-galactopyranoside, respectively. The water solubility of Ast, Ast-Gal1, and Ast-Gal2 were 28.2 ± 1.2 mg/L, 38,300 ± 3.5 mg/L, and 38,800 ± 2.8 mg/L, respectively. The SC50 value (the concentration required to scavenge 50% of the ABTS[rad]+ ) of Ast, Ast-Gal1, and Ast-Gal2 were 5.1 ± 1.6 μM, 6.5 ± 0.4 μM, and 4.9 ± 1.1 μM, respectively. The IC50 values (the half maximal inhibitory concentration) of Ast, Ast-Gal1, and Ast-Gal2 against angiotensin converting enzyme (ACE) were 171.0 ± 1.2 μM, 186.0 μM, and 139.0 ± 0.2 μM, respectively.

Original languageEnglish
Pages (from-to)59-67
Number of pages9
JournalEnzyme and Microbial Technology
Volume103
DOIs
Publication statusPublished - 2017 Aug 1

Fingerprint

Galactosidases
Galactosides
Bacilli
Bacillus
Galactose
Solubility
Anti-Allergic Agents
Water
Peptidyl-Dipeptidase A
Chromatography
Flavonoids
Oxidants
Silicon Dioxide
Inhibitory Concentration 50
Anti-Inflammatory Agents
Magnetic Resonance Spectroscopy
Nuclear magnetic resonance
HIV
Pressure
kaempferol

Keywords

  • ACE inhibition
  • Antioxidant activity
  • Astragalin
  • Astragalin galactoside
  • β-Galactosidase

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Applied Microbiology and Biotechnology

Cite this

Synthesis and characterization of novel astragalin galactosides using β-galactosidase from Bacillus circulans. / Han, Songhee; Hanh Nguyen, Thi Thanh; Hur, Jaewon; Kim, Nahyun M.; Kim, Seong Bo; Hwang, Kyeong Hwan; Moon, Young Hwan; Kang, Choongil; Chung, Byoungsang; Kim, Young Min; Kim, Tae Sung; Park, Jun Seong; Kim, Doman.

In: Enzyme and Microbial Technology, Vol. 103, 01.08.2017, p. 59-67.

Research output: Contribution to journalArticle

Han, S, Hanh Nguyen, TT, Hur, J, Kim, NM, Kim, SB, Hwang, KH, Moon, YH, Kang, C, Chung, B, Kim, YM, Kim, TS, Park, JS & Kim, D 2017, 'Synthesis and characterization of novel astragalin galactosides using β-galactosidase from Bacillus circulans', Enzyme and Microbial Technology, vol. 103, pp. 59-67. https://doi.org/10.1016/j.enzmictec.2017.05.003
Han, Songhee ; Hanh Nguyen, Thi Thanh ; Hur, Jaewon ; Kim, Nahyun M. ; Kim, Seong Bo ; Hwang, Kyeong Hwan ; Moon, Young Hwan ; Kang, Choongil ; Chung, Byoungsang ; Kim, Young Min ; Kim, Tae Sung ; Park, Jun Seong ; Kim, Doman. / Synthesis and characterization of novel astragalin galactosides using β-galactosidase from Bacillus circulans. In: Enzyme and Microbial Technology. 2017 ; Vol. 103. pp. 59-67.
@article{f9bee2b3d1ae415883651e5d05cabf8d,
title = "Synthesis and characterization of novel astragalin galactosides using β-galactosidase from Bacillus circulans",
abstract = "Astragalin (kaempferol-3-O-β-D-glucopyranoside, Ast) is a kind of flavonoid known to have anti-oxidant, anti-HIV, anti-allergic, and anti-inflammatory effects. It has low solubility in water. In this study, novel astragalin galactosides (Ast-Gals) were synthesized using β-galactosidase from Bacillus circulans and reaction conditions were optimized to increase the conversion yield of astragallin. Purified Ast-Gal1 (11.6{\%} of Ast used, w/w) and Ast-Gal2 (6.7{\%} of Ast used, w/w) were obtained by medium pressure chromatography (MPLC) with silica C18 column and open column packed with Sephadex LH-20. The structures of Ast-Gal1 and Ast-Gal2 were identified by nuclear magnetic resonance (NMR) to be kaempferol-3-O-β-D-glucopyranosyl-(1 → 6)-β-D-galactopyranoside and kaempferol-3-O-β-D-glucopyranosyl-(1 → 6)-β-D-galactopyranosyl-(1 → 4)-β-D-galactopyranoside, respectively. The water solubility of Ast, Ast-Gal1, and Ast-Gal2 were 28.2 ± 1.2 mg/L, 38,300 ± 3.5 mg/L, and 38,800 ± 2.8 mg/L, respectively. The SC50 value (the concentration required to scavenge 50{\%} of the ABTS[rad]+ ) of Ast, Ast-Gal1, and Ast-Gal2 were 5.1 ± 1.6 μM, 6.5 ± 0.4 μM, and 4.9 ± 1.1 μM, respectively. The IC50 values (the half maximal inhibitory concentration) of Ast, Ast-Gal1, and Ast-Gal2 against angiotensin converting enzyme (ACE) were 171.0 ± 1.2 μM, 186.0 μM, and 139.0 ± 0.2 μM, respectively.",
keywords = "ACE inhibition, Antioxidant activity, Astragalin, Astragalin galactoside, β-Galactosidase",
author = "Songhee Han and {Hanh Nguyen}, {Thi Thanh} and Jaewon Hur and Kim, {Nahyun M.} and Kim, {Seong Bo} and Hwang, {Kyeong Hwan} and Moon, {Young Hwan} and Choongil Kang and Byoungsang Chung and Kim, {Young Min} and Kim, {Tae Sung} and Park, {Jun Seong} and Doman Kim",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.enzmictec.2017.05.003",
language = "English",
volume = "103",
pages = "59--67",
journal = "Enzyme and Microbial Technology",
issn = "0141-0229",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Synthesis and characterization of novel astragalin galactosides using β-galactosidase from Bacillus circulans

AU - Han, Songhee

AU - Hanh Nguyen, Thi Thanh

AU - Hur, Jaewon

AU - Kim, Nahyun M.

AU - Kim, Seong Bo

AU - Hwang, Kyeong Hwan

AU - Moon, Young Hwan

AU - Kang, Choongil

AU - Chung, Byoungsang

AU - Kim, Young Min

AU - Kim, Tae Sung

AU - Park, Jun Seong

AU - Kim, Doman

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Astragalin (kaempferol-3-O-β-D-glucopyranoside, Ast) is a kind of flavonoid known to have anti-oxidant, anti-HIV, anti-allergic, and anti-inflammatory effects. It has low solubility in water. In this study, novel astragalin galactosides (Ast-Gals) were synthesized using β-galactosidase from Bacillus circulans and reaction conditions were optimized to increase the conversion yield of astragallin. Purified Ast-Gal1 (11.6% of Ast used, w/w) and Ast-Gal2 (6.7% of Ast used, w/w) were obtained by medium pressure chromatography (MPLC) with silica C18 column and open column packed with Sephadex LH-20. The structures of Ast-Gal1 and Ast-Gal2 were identified by nuclear magnetic resonance (NMR) to be kaempferol-3-O-β-D-glucopyranosyl-(1 → 6)-β-D-galactopyranoside and kaempferol-3-O-β-D-glucopyranosyl-(1 → 6)-β-D-galactopyranosyl-(1 → 4)-β-D-galactopyranoside, respectively. The water solubility of Ast, Ast-Gal1, and Ast-Gal2 were 28.2 ± 1.2 mg/L, 38,300 ± 3.5 mg/L, and 38,800 ± 2.8 mg/L, respectively. The SC50 value (the concentration required to scavenge 50% of the ABTS[rad]+ ) of Ast, Ast-Gal1, and Ast-Gal2 were 5.1 ± 1.6 μM, 6.5 ± 0.4 μM, and 4.9 ± 1.1 μM, respectively. The IC50 values (the half maximal inhibitory concentration) of Ast, Ast-Gal1, and Ast-Gal2 against angiotensin converting enzyme (ACE) were 171.0 ± 1.2 μM, 186.0 μM, and 139.0 ± 0.2 μM, respectively.

AB - Astragalin (kaempferol-3-O-β-D-glucopyranoside, Ast) is a kind of flavonoid known to have anti-oxidant, anti-HIV, anti-allergic, and anti-inflammatory effects. It has low solubility in water. In this study, novel astragalin galactosides (Ast-Gals) were synthesized using β-galactosidase from Bacillus circulans and reaction conditions were optimized to increase the conversion yield of astragallin. Purified Ast-Gal1 (11.6% of Ast used, w/w) and Ast-Gal2 (6.7% of Ast used, w/w) were obtained by medium pressure chromatography (MPLC) with silica C18 column and open column packed with Sephadex LH-20. The structures of Ast-Gal1 and Ast-Gal2 were identified by nuclear magnetic resonance (NMR) to be kaempferol-3-O-β-D-glucopyranosyl-(1 → 6)-β-D-galactopyranoside and kaempferol-3-O-β-D-glucopyranosyl-(1 → 6)-β-D-galactopyranosyl-(1 → 4)-β-D-galactopyranoside, respectively. The water solubility of Ast, Ast-Gal1, and Ast-Gal2 were 28.2 ± 1.2 mg/L, 38,300 ± 3.5 mg/L, and 38,800 ± 2.8 mg/L, respectively. The SC50 value (the concentration required to scavenge 50% of the ABTS[rad]+ ) of Ast, Ast-Gal1, and Ast-Gal2 were 5.1 ± 1.6 μM, 6.5 ± 0.4 μM, and 4.9 ± 1.1 μM, respectively. The IC50 values (the half maximal inhibitory concentration) of Ast, Ast-Gal1, and Ast-Gal2 against angiotensin converting enzyme (ACE) were 171.0 ± 1.2 μM, 186.0 μM, and 139.0 ± 0.2 μM, respectively.

KW - ACE inhibition

KW - Antioxidant activity

KW - Astragalin

KW - Astragalin galactoside

KW - β-Galactosidase

UR - http://www.scopus.com/inward/record.url?scp=85019914830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019914830&partnerID=8YFLogxK

U2 - 10.1016/j.enzmictec.2017.05.003

DO - 10.1016/j.enzmictec.2017.05.003

M3 - Article

C2 - 28554386

AN - SCOPUS:85019914830

VL - 103

SP - 59

EP - 67

JO - Enzyme and Microbial Technology

JF - Enzyme and Microbial Technology

SN - 0141-0229

ER -